Davide Leone & Partners Investment Company’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-14,088
Closed -$1.67M 136
2021
Q1
$1.67M Hold
14,088
0.21% 72
2020
Q4
$1.66M Buy
+14,088
New +$1.64M 0.17% 61

Davide Leone & Partners Investment Company's CBPO Position: Q2 2021 in Review

Davide Leone & Partners Investment Company sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 14,088 shares — an estimated $1.67M sold.

Davide Leone & Partners Investment Company first reported a position in CBPO in Q4 2020 and held it in 2 quarters. The position peaked at $1.67M in Q1 2021. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

  • Davide Leone & Partners Investment Company reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
  • Davide Leone & Partners Investment Company sold 14,088 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $1.67M.
  • Davide Leone & Partners Investment Company first reported a position in China Biologic Products Holdings, Inc. in Q4 2020 and held it in 2 quarters.
  • Davide Leone & Partners Investment Company's China Biologic Products Holdings, Inc. position peaked at $1.67M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on Davide Leone & Partners Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.